1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Pharmaceuticals Holding Co., Ltd
  6. News
  7. Summary
    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

(601607)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Shanghai Pharmaceuticals Holding Co., Ltd Approves Cash Dividend for the Year 2020, Payable on 27 August 2021

06/29/2021 | 07:20am EDT

Shanghai Pharmaceuticals Holding Co. Ltd. announced that at its AGM held on 29 June 2021, the shareholders approved distribute a cash dividend of RMB 4.80 (tax inclusive) for every ten shares for year 2020. The cash dividends are expected to be paid on 27 August 2021, to Shareholders whose names appear on the H Share register of members of the company on 16 July 2021, (the record date). Holders of H Shares whose names appear on the register of members of the company at the close of business on the Record Date are entitled to the cash dividends.


ę S&P Capital IQ 2021
All news about SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
04/28Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the First Quarte..
CI
04/18Shanghai factories struggle with restarts as city aims to ease lockdown
RE
04/18Shanghai factories sputter towards reopening as city aims to ease lockdown
RE
04/18Shanghai factories sputter towards reopening as city aims to ease lockdown
RE
04/18Shanghai factories sputter towards reopening as city aims to ease lockdown
RE
04/18Tesla, others prepare Shanghai factory restarts as city aims to ease lockdown
RE
03/29Shanghai Pharmaceuticals Holding Co., Ltd Announces Final Dividend for the Year Ended D..
CI
03/29Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Full Year En..
CI
03/25Shanghai Pharmaceuticals Holding Co., Ltd announced that it has received CNY 13.9745523..
CI
03/22Shanghai Pharma Denies Working With Japan's Shionogi on COVID-19 Drug; Shanghai Shares ..
MT
More news
Financials
Sales 2022 236 B 34 836 M 34 836 M
Net income 2022 5 143 M 758 M 758 M
Net Debt 2022 13 559 M 1 999 M 1 999 M
P/E ratio 2022 12,1x
Yield 2022 2,54%
Capitalization 65 732 M 9 689 M 9 689 M
EV / Sales 2022 0,34x
EV / Sales 2023 0,35x
Nbr of Employees 47 056
Free-Float 47,0%
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | 601607 | CNE000000C82 | MarketScreener
Technical analysis trends SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 19,99 CNY
Average target price 21,60 CNY
Spread / Average Target 8,05%
EPS Revisions
Managers and Directors
Man Cho President & Executive Director
Bo Shen Chief Financial Officer, Executive Director & VP
Jun Zhou Chairman
Liang Hong Independent Non-Executive Director
Jiang Nan Cai Independent Non-Executive Director
Sector and Competitors